HYLORIS PHARMACEUTICALS SA (HYL.BR) Stock Cash Flow
Europe - Euronext Brussels - EBR:HYL - BE0974363955 - Common Stock
8 EUR
0 (0%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -6.41M | -6.34M | -15.76M | -10.77M | -11.58M | |||
| Depreciation Amortization | 685.00K | 648.00K | 349.00K | 196.00K | 137.00K | |||
| Change In Working Capital | -3.22M | -1.42M | 2.18M | -1.98M | -577.00K | |||
| Interest Paid | N/A | N/A | N/A | 1.88M | N/A | |||
| Taxes Paid | N/A | N/A | N/A | 315.00K | N/A | |||
| Other non cash items | 2.06M | 206.00K | 41.00K | 666.00K | 769.00K | |||
| OPERATING CASH FLOW | -6.89M | -6.90M | -12.81M | -13.02M | -11.25M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -473.00K | -297.00K | -750.00K | -739.00K | -1.06M | |||
| Other Investing Activity | -967.00K | 556.00K | 10.64M | -10.63M | -2.01M | |||
| INVESTING CASH FLOW | -1.44M | 259.00K | 9.89M | -11.37M | -3.08M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -329.00K | -168.00K | -119.00K | -7.46M | -62.00K | |||
| Stock Issued/Repurchased | N/A | N/A | 0.00 | 2.83M | N/A | |||
| Other Financing Activity | 5.00K | 0.00 | -12.00K | 12.46M | N/A | |||
| FINANCING CASH FLOW | -324.00K | -168.00K | -131.00K | 7.84M | -62.00K | |||
| CHANGE IN CASH | -8.81M | -6.81M | -3.05M | -16.55M | -14.39M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -6.89M | -6.90M | -12.81M | -13.02M | -11.25M | |||
| Capital Expenditure | -473.00K | -297.00K | -750.00K | -739.00K | -1.06M | |||
| FREE CASH FLOW | -7.36M | -7.20M | -13.56M | -13.76M | -12.31M | |||
All data in EUR